Curaleaf Holdings, Inc. - CEO, Joseph Lusardi
CEO, Joseph Lusardi
Source: The Boston Globe
  • Curaleaf Holdings (CSE:CURA) has received Essential Services Designation to continue operating in key markets despite the COVID-19 crisis
  • The designation has also been offered to basic goods providers like grocery stores and pharmacies
  • The company has adjusted its operating hours to cater for increased demand, as well as the prioritization of vulnerable customers
  • Greater social distancing, sanitation and hygiene measures have also implemented at its outlets
  • Curaleaf Holdings (CURA) is currently up 7.37 per cent to C$4.81 per share, with a market cap of $2.28 billion

Curaleaf Holdings (CSE:CURA) has received Essential Services Designation to continue operating in key markets despite the COVID-19 crisis.

Businesses that have received the designation include all vital healthcare operations. This extends to research and laboratory services, key infrastructure, utilities, mail and shipping services, grocery stores and pharmacies.

However, the opportunity to continue with the provision of these services is dependent on the implementation of strict new policies.

As such, Curaleaf has said that it will enforce social distancing, increase sanitization and hygiene requirements, and use technology to reduce the extent of human to human contact.

Joseph Lusardi, CEO of Curaleaf Holdings, said that the company is responding as quickly as possible to ensure its continued service to customers in need.

“We have never been more committed to providing our vital services and products and will continue to do everything we can to fulfill that mission while protecting the wellbeing of our dedicated employees.

“In these difficult times, we will be hiring employees and working with local organizations to provide job opportunities to those who are out of work,” he added.

Curaleaf’s dispensaries in Arizona, Florida, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York and Oregon will remain open. However, some of these outlets will be restricted to either medical supply or delivery only.

Operating times at these locations will be adjusted to field the increase in demand. Curaleaf has said that it will also prioritize the needs of vulnerable patients, such as senior citizens and those with existing health conditions.

Curaleaf Holdings (CURA) is currently up 7.37 per cent to C$4.81 per share at 9:32am EST.

More From The Market Online

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.

The Market Online’s Weekly Cannabis Report – April 12, 2024

Canada’s cannabis stock market fluctuated this week thanks to a combination of industry-specific developments and broader market trends

Avicanna completes topical gel study

Avicanna (TSX:AVCN) has completed its observational real-world evidence study of its RHO Phyto branded cannabigerol gel.